Zdrowie i gospodarka · 23/12/2010

FDA Requests Public Comment on Proposed Collection of Information for Labeling of Antibacterial Drugs and Devices

The Food and Drug Administration (FDA) is seeking public input on a proposed collection of information related to labeling of systemic antibacterial drug products and antimicrobial susceptibility testing devices, as outlined in its recent guidance document.